New fundraise positions MycoTechnology to take its mushroom mycelia platform onto the global stage
MycoTechnology, Inc. has set its sights on achieving global scale and realizing its innovation pipeline after securing a funding injection of $85 million. The recently concluded Series E fundraise represents the Colorado-based company’s largest single round of financing since it was established in 2013, bringing total fundraising to-date to more than $200 million.
This new investment will allow MycoTechnology to further capitalize on its proprietary fermentation platform, continuing to impact food and nutrition around the world. The company is now positioned to bring its unique product portfolio to even more consumers globally, with a focus on expanding in Europe, Asia, and the Middle East.